Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia.
作者信息
Cancel-Artau Karina J, Marrero-Pérez Angélica C, Michelén-Gómez Eduardo A, Sánchez-Flores Xavier
机构信息
Department of Dermatology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.
University of Medicine and Health Sciences, Basseterre, Saint Kitts and Nevis.
出版信息
JAAD Case Rep. 2024 Jan 27;45:113-116. doi: 10.1016/j.jdcr.2024.01.014. eCollection 2024 Mar.
Abstract
摘要
Zotero 插件